Skip to main content
Equibles

DAFNA Capital Management LLC

Position in GPCR — Structure Therapeutics Inc.

CIK 1389933 LOS ANGELES, CA
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,495,655
+$254,355 QoQ
Shares Held
46,500
0.0% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#77
of 190 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DAFNA Capital Management LLC holds $345,637,467 across 65 Biotechnology names. GPCR ranks #26 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 562,630 $105,369,346
2 NKTR
Nektar Therapeutics
 318,380 $22,226,107
3 DNLI
Denali Therapeutics Inc.
 739,014 $19,007,440
4 IDYA
IDEAYA Biosciences, Inc.
 497,240 $18,532,134
5 XENE
Xenon Pharmaceuticals Inc.
 250,772 $15,136,597
6 CYTK
Cytokinetics Inc
 171,998 $14,652,509
7 RCUS
Arcus Biosciences, Inc.
 441,829 $13,621,588
8 ASND
Ascendis Pharma A/S
 48,469 $12,927,651

All Filings in GPCR

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,495,655 46,500
2026-03-31 $2,241,300 46,500
2025-12-31 $2,573,350 37,000
2025-09-30 $1,652,000 59,000
2025-06-30 $1,223,660 59,000
2025-03-31 $1,021,290 59,000
2024-12-31 $962,760 35,500
2024-09-30 $1,492,260 34,000
2024-06-30 $196,350 5,000